Completed OBSERVATIONAL NCT06453707

SpinChip Hs-cTnI Sample Type Validation (HEAT-2)

Sample Type Validation: Finger Prick and Plasma vs Whole Blood in a Clinical Setting for the SpinChip High-sensitivity Cardiac Troponin I (SpinChip Hs-cTnI) Test

Sponsor: Aurevia

Conditions Acute Myocardial Infarction

Interventions SpinChip hs-cTnI

Updated 3 times since 2024 Last updated: Aug 21, 2024 Started: Apr 12, 2024 Primary completion: Jul 3, 2024 Completion: Jul 3, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06453707, this observational or N/A phase trial focuses on Acute Myocardial Infarction and remains completed. Sponsored by Aurevia, it has been updated 3 times since 2024, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

3 versions recorded

Jun 2025 — Present [monthly]

Completed
Sep 2024 — Jun 2025 [monthly]

Completed

Status: Recruiting → Completed
Jul 2024 — Sep 2024 [monthly]

Recruiting

First recorded

Apr 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aurevia
SpinChip Diagnostics ASA
University Hospital, Akershus

Data source: SpinChip Diagnostics ASA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lørenskog, Norway